[HTML][HTML] Palmitoylethanolamide reduces neuropsychiatric behaviors by restoring cortical electrophysiological activity in a mouse model of mild traumatic brain injury

F Guida, S Boccella, M Iannotta… - Frontiers in …, 2017 - frontiersin.org
Traumatic brain injury (TBI) represents a major public health problem, which is associated
with neurological dysfunction. In severe or moderate cases of TBI, in addition to its high …

Micronized palmitoylethanolamide reduces the symptoms of neuropathic pain in diabetic patients

C Schifilliti, L Cucinotta, V Fedele… - Pain research and …, 2014 - Wiley Online Library
The present study evaluated the effectiveness of micronized palmitoylethanolamide (PEA‐
m) treatment in reducing the painful symptoms experienced by diabetic patients with …

[HTML][HTML] A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury

I Paterniti, D Impellizzeri, R Di Paola, M Navarra… - Journal of …, 2013 - Springer
Background It has recently been demonstrated that palmitoylethanolamide (PEA), an
endogenous lipid amide belonging to the N-acylethanolamine family, exerts neuroprotection …

[HTML][HTML] Alternative targets to fight Alzheimer's disease: focus on astrocytes

M Valenza, R Facchinetti, G Menegoni, L Steardo… - Biomolecules, 2021 - mdpi.com
The available treatments for patients affected by Alzheimer's disease (AD) are not curative.
Numerous clinical trials have failed during the past decades. Therefore, scientists need to …

Palmitoylethanolamide counteracts reactive astrogliosis induced by β‐amyloid peptide

C Scuderi, G Esposito, A Blasio… - Journal of Cellular …, 2011 - Wiley Online Library
Emerging evidence indicates that astrogliosis is involved in the pathogenesis of
neurodegenerative disorders. Our previous findings suggested cannabinoids and Autacoid …

Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models

O Sasso, G Moreno-Sanz, C Martucci, N Realini… - PAIN®, 2013 - Elsevier
Fatty acid ethanolamides (FAEs), which include palmitoylethanolamide (PEA) and
oleoylethanolamide (OEA), are endogenous agonists of peroxisome proliferator-activated …

[HTML][HTML] A randomized controlled trial assessing the safety and efficacy of palmitoylethanolamide for treating diabetic-related peripheral neuropathic pain

E Pickering, EL Steels, KJ Steadman, A Rao… - …, 2022 - Springer
Background Peripheral neuropathy is a common complication of diabetes. The management
of the associated neuropathic pain remains difficult to treat. Objective This study explored …

[HTML][HTML] DHA/EPA (Omega-3) and LA/GLA (Omega-6) as bioactive molecules in neurodegenerative diseases

C Kousparou, M Fyrilla, A Stephanou… - International Journal of …, 2023 - mdpi.com
Neurodegenerative diseases are characterized by neuroinflammation, neuronal depletion
and oxidative stress. They coincide with subtle chronic or flaring inflammation, sometimes …

Palmitic acid triggers inflammatory responses in N42 cultured hypothalamic cells partially via ceramide synthesis but not via TLR4

D Sergi, AC Morris, DE Kahn, FH McLean… - Nutritional …, 2020 - Taylor & Francis
A high-fat diet induces hypothalamic inflammation in rodents which, in turn, contributes to
the development of obesity by eliciting both insulin and leptin resistance. However, the …

[HTML][HTML] Effect of PEA-OXA on neuropathic pain and functional recovery after sciatic nerve crush

E Gugliandolo, R D'amico, M Cordaro, R Fusco… - Journal of …, 2018 - Springer
Background Animal models of sciatic nerve injury are commonly used to study neuropathic
pain as well as axon regeneration. Inflammation/immune response at the site of nerve lesion …